Giant Biogene Holding Co., Ltd.
2367
Pozycja w akcjach
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Cena akcji
$2.67
Kapitalizacja rynkowa
$2.84B
Zmiana (1 dzień)
-6.09%
Zmiana (1 rok)
-46.20%
Kraj
CN
Handel Giant Biogene Holding Co., Ltd. (2367)
Kategoria
Consumer Defensive
Zyski dla Giant Biogene Holding Co., Ltd. (2367)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Giant Biogene Holding Co., Ltd., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Giant Biogene Holding Co., Ltd. od 2019 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2025 | $335.93M | -0.23% |
| 2024 | $336.72M | 36.58% |
| 2023 | $246.53M | 44.39% |
| 2022 | $170.74M | 11.54% |
| 2021 | $153.07M | 2.75% |
| 2020 | $148.98M | 53.23% |
| 2019 | $97.22M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $20.38B | - |
US
|
|
| $9.83B | - |
FR
|
|
| $2.94B | - |
US
|
|
| $1.55B | - |
IN
|
|
| $517.00M | - |
US
|
